Raviv Zoller
Analyst · Barclays
Thanks, Peggy, and welcome, everyone. Thank you all for joining us for our 2024 annual earnings. This will be my final call as ICL's CEO and I'm pleased to reflect on the past 28 quarters and to share our results with you once again today. While there are still some challenges related to the situation in Israel, we successfully managed to minimize the impact of war-related disruptions throughout 2024 and the situation is getting better now. Please turn to Slide 3 for a brief overview of 2024, which wrapped up the year of continued market share gains for our specialties driven business. Sales were $6.841 billion, while adjusted EBITDA was $1.469 billion, representing a margin of 21%. Adjusted diluted earnings per share was $0.38 for 2024. Throughout the year, we maintained our overall momentum despite persistent potash pricing headwinds. For 2024, potash prices decreased 24% versus the prior year. However, our sustained focus on our specialties driven businesses [indiscernible] drive annual EBITDA up 8% to these 3 segments: Industrial Products, Phosphate Solutions and Growing Solutions. In total, our specialties businesses represented 70% of 2024 EBITDA and 73% of fourth quarter EBITDA. As always, we continue to focus on strong cash generation which resulted in free cash flow of $758 million for the full year. Additionally, we wrapped up the year by delivering a total of $242 million dividend distribution with an industry-leading dividend yield of 3.8%. Once again, even in a very challenging year, we delivered a total return ahead of our peers in 2024. We had a number of big wins in 2024 as we expanded strategic relationships and accelerated the launch of innovative new products across all of our specialties driven business. We also delivered on our efficiency plans for targeted cost savings. Finally, as I mentioned, we contained war-related disruptions in 2024 and maintained good production. And for 2025, we expect to move it [indiscernible] overall. I would ask you to turn now to Slide 4 and a look at some key fourth quarter and full year financial metrics. As you can see, we ended the year close to the high end of our upgraded guidance with fourth quarter specialty-driven EBITDA of $253 million, up 20% year-over-year. We also delivered an increase in consolidated adjusted EBITDA margin for the fourth quarter, which came in at 22%, even as EBITDA decreased by $10 million year-over-year. Meanwhile, operating cash flow in the fourth quarter for this year was in line with the fourth quarter of [ 2023 ]. And in my view, our balance sheet as we exited 2024 was the strongest in recent years. Let's start with the review of our divisions and begin with our Industrial Products business on Slide 5. For 2024, sales of $1.239 billion were up slightly versus 2023 as was EBITDA of $281 million. For the traditionally soft fourth quarter, sales were down versus the prior year. However, EBITDA of $70 million improved significantly, up 25% on cost efficient. While EBITDA margin also showed a dramatic increase and moved up from 19% to 25%. For 2024, we continue to strengthen our partnerships and customer relationships as these long-term alliances contribute to our market share gains and accounts. We had another solid year for specialty minerals as sales increased year-over-year. Annual sales of clear brine fluids, which are used in the oil and gas industry, decreased versus the prior year due to drilling segments. However, these may begin to vary in a positive way due to recent policy shift. Importantly, Industrial Products delivered a gain in its sales for its phosphorus based additive flame retardants in the fourth quarter. This business has begun to benefit from new antidumping measures implemented in the EU in 2024 and U.S. customers are also expected to be influenced for antidumping proceedings now pending in the U.S. As a result of this, we saw good customer uptake for our sustainable very phosphorus-based flame retardants with some key partners already transitioning production lines to this innovative product. In other new product news, industrial products recently unveiled a revolutionary sustainable solution for the treatment of [indiscernible]. On Slide 6, you will see our potash division results for 2024 with sales of $1.656 billion and EBITDA of $492 million. Our average potash price was down nearly $100 CIF per ton versus 23, while total sales volume was down approximately 127,000 metric tons at the same time. In total, we sold 4.6 million metric tons of potash in 2024, and we expect to benefit from our decision to the first and fourth quarter sales into 2025. In Spain, we had record potash production at our Suria site delivering more than 800,000 metric tons. Despite the war and while somewhat short staffed, we were able to maintain fairly normal as production levels in Israel. And while we still continue to face operational and logistical challenges at our Dead Sea operations, we adopted some long-term risk mitigation measures or related infrastructure issues. In 2024, we saw a significant improvement in annual cost per ton at our Spanish operations and in total. For potash overall, we benefited from our ongoing operational and efficiency efforts in 2024 and we expect to see continued improvements in [ 2026 ]. Turning to Slide 7 in our Phosphate Solutions division where 2024 sales were [ $2.250 billion ]. Results in general, were ahead of our expectations despite lower [indiscernible] acid prices as we benefited from favorable volume and mix as well as lower raw material costs. Commodity prices were also higher than expected in 2024, but lower versus the prior year. For the fourth quarter, we saw a slight year-over-year decrease in phosphate solutions sales as an increase in external sales do not offset lower internal sales. Annual EBITDA of $559 million also slightly decreased on a year-over-year basis. However, EBITDA margin expanded to 25%. We were able to improve this rate as we prioritize cost savings and production efficiencies through 2024. We also significantly benefited from higher volumes and lower raw material costs. Our Phosphate Specialties results were aligned with market dynamics as expected. North America and Europe were relatively stable, but remained competitive, while South America was influenced by significant influence from China. Overall, we maintained our focus on market share and volume gains, while delivering new products and expanding our reach, including into [indiscernible]. We're also looking into additional food specialty opportunities, including geographic expansion, and in 2024, we introduced a new alternative [indiscernible]. Our Light pH joint venture in China delivered multiple production acres, including another overall record year continued strong demand for battery grade [indiscernible]. One of the strengths of our Light pH facility is the ability to flex between customer demand for battery and agriculture solutions, and our team there does an excellent job of optimizing between the two. In North America, we've been hosting customer meetings at our Battery Materials innovation and qualification Center in St. Louis, which became operational in less than 1 year. For our commercial LFP plant in the U.S., we are now finalizing the detailed engineering profit. As mentioned in previous earnings calls, we continue to align this capital spend to match anticipated customer demand time. For Europe, in January of this year, we signed a strategic agreement with Dynanonic, currently #2 in the world in capital material capacity to produce lithium iron phosphate at our existing site in [ Sallent ] Spain. While this project is currently only in its planning stages, it demonstrates our commitment to developing high-quality solutions for sustainable supply chain. Turning now to Slide 8 and our Growing Solutions business division for 2024 sales of $1.950 billion were down year-over-year. EBITDA of $202 million increased [ 70% ] for the same time frame, while EBITDA margin of 10% expanded significantly versus the prior year. For the fourth quarter, we saw a similar improvement in EBITDA, which was up significantly and margin rate, which improved 12% from 3% in the fourth quarter of 2023. Overall growth and profitability was driven by efficiency efforts and improved product mix as well as lower raw material costs. In 2024, the business continued to target market share growth via both M&A and new product innovation. In the U.K., we completed a bolt-on acquisition toward the end of the year to strengthen our position in the surf and landscape market. While based in the U.K., GreenBest is reknown for its specialty granular and liquid nutrition products serving all global markets. In North America, we had record sales volumes in 2024 with strong growth in Mexico and Canada. In Asia, we achieved record-breaking annual sales volumes for Specialty Agriculture Fertilizers. Fourth quarter sales in Brazil were lower than expected due to significant currency fluctuations, site liquidity and soft soybean crop economics given lower commodity prices and margins. However, for the full year, we saw improved profitability and further market share growth in Brazil. In 2024, Growing Solutions entered the biological fertilizer business, delivered new product sales of more than $250 million and expanded its R&D efforts and innovation partnerships. I would now like to wrap up with a few highlights on Slide 9. Once again, solid execution from across the entire company helped deliver winning results for ICL. We continue to drive long-term growth in specialties driven EBITDA, which meaningfully sets us apart from our commodity-based peers. We enhanced our partnerships across 3 of our specialty-driven businesses, Industrial Products, Phosphate Solutions and Growing Solutions as we strive to work with the best to achieve our goals and expand our presence globally. In some instances, this means extending customer relationships over the long term so we can both benefit during the good times and whether the bad times together. In other situations, we bring our expertise to our customers to help them succeed. And of course, we are always working to find the best partners to help get our products to market in every region. We made 3 complementary acquisitions while also driving new product innovation. We will continue to innovate as it is an inherent part of ICL's G&A and one of the key areas that helps us [indiscernible] us. We advanced our battery material aspirations into Europe and receive partnership support as well as government funding, and we remain on track to strengthen our leadership positions in 2025. We are already leaders in bromine and specialty phosphates, and we are now moving to the top of Growing Solutions by consistently improving our market share and position. As you can see on Slide 10, we delivered shareholder value ahead of our peers once again and a very challenging year for our industry. And in spite of geopolitical challenges well beyond our control. In 2024, we also actively managed various concession renewal efforts. And for the [indiscernible] specifically, we provided feedback on the draft government report and participated in [indiscernible] Committee meeting. During 2024, we also successfully settled a large portion of outstanding [ lead ] lines. We also continue to advance our sustainability efforts and improved our rankings across multiple key global metrics. And finally, on the occasion of my final earnings call with ICL, I want to thank my hard-working and dedicated team spread across the globe. Together, we shared the achievements of the past 7 years, and I would not have been able to reach this point without the support from each and every ICL in [indiscernible]. Thank you. I also want to congratulate Elad Aharonson, our new CEO. Elad has earned his promotion by delivering proven business performance and clear demonstration of leadership skills. He is passionate about ICL's future opportunities, and he will join us today for our Q&A session so that you can get to know him. Good luck, Elad, from all of our ICL colleagues. And with that, I would now like to turn the call over to Aviram.